Citius Oncology, Inc. (CTOR)
NASDAQ: CTOR · Real-Time Price · USD
1.120
+0.010 (0.89%)
At close: Dec 5, 2025, 4:00 PM EST
1.140
+0.020 (1.79%)
After-hours: Dec 5, 2025, 7:59 PM EST
Citius Oncology Market Cap
Citius Oncology has a market cap or net worth of $93.53 million as of December 5, 2025. Its market cap has increased by 35.22% in one year.
Market Cap
93.53M
Enterprise Value
97.33M
1-Year Change
35.22%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since December 8, 2022, Citius Oncology's market cap has increased from $90.21M to $93.53M, an increase of 3.67%. That is a compound annual growth rate of 1.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 92.70M | 12.66% |
| Dec 31, 2024 | 82.29M | -15.88% |
| Dec 29, 2023 | 97.81M | 7.68% |
| Dec 30, 2022 | 90.84M | 0.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |